Neurogene’s Rett syndrome gene therapy has preliminary data supporting safety and efficacy of the one-time treatment. But a late-breaking report of a serious complication in a patient who received the high dose sent shares of the biotech downward.
The generation that faced discrimination, ostracism, and the AIDS epidemic now faces old age. Many struggle with isolation along with a host of pressing health…
Stimulant use is on the rise across the United States. In 2022, more than 10.2 million people aged 12 and older misused stimulants—a class of…
NASA have discovered a planet bigger than Earth with a gas that is ‘only produced by life’.
Nature Communications – The power consumption of control/readout electronics remains a limiting factor for large-scale quantum computers. Here, the authors demonstrate III–V semiconductor and…
Nature Communications – The operational lifetimes of n-i-p perovskite solar cells have been limited by the layer-to layer ion diffusion in the perovskite/hole-transport layer heterojunction.…
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.
Real, full-fat cheese & other dairy has great macros and is a good source of vitamins/minerals. But,it carries an addictive molecule that causes many people…
A new depression treatment developed by startup Neumora Therapeutics failed in a Phase 3 clinical trial — the company’s first late-stage readout.
An adult man with low-volume liver metastases from grade 3 rectal neuroendocrine tumor (Ki67 index of 25%) sequentially underwent multiple systemic therapies. Gallium (88Ga)-DOTATATE scan…
